Olav Mella, MD PhD
Dept. of Oncology, Haukeland University Hospital, Bergen, Norway · Department of Oncology, Haukeland University Hospital, Bergen, Norway · Department of Oncology and Medical Physics, Haukeland University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Olav Mella, MD PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:12 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT02229942 · B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.Haukeland University Hospital · completed · Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME) · principal investigator
- Ph2NCT01705392 · Bevacizumab vs Dacarbazine in Metastatic MelanomaHaukeland University Hospital · terminated · Metastatic Malignant Melanoma, Unresectable Malignant Melanoma · study director
- Ph2/Ph3NCT00848692 · Drug Intervention in Chronic Fatigue SyndromeHaukeland University Hospital · completed · Chronic Fatigue Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.